HighTower Advisors LLC Buys 24,715 Shares of Rockwell Medical, Inc. (NASDAQ:RMTI)

HighTower Advisors LLC increased its stake in shares of Rockwell Medical, Inc. (NASDAQ:RMTI) by 75.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 57,413 shares of the company’s stock after buying an additional 24,715 shares during the quarter. HighTower Advisors LLC owned 0.18% of Rockwell Medical worth $228,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Concurrent Investment Advisors LLC purchased a new position in Rockwell Medical during the 3rd quarter worth $40,000. Verus Capital Partners LLC bought a new position in shares of Rockwell Medical during the third quarter valued at about $51,000. Beacon Financial Advisory LLC bought a new stake in Rockwell Medical in the 3rd quarter worth about $98,000. Renaissance Technologies LLC grew its position in Rockwell Medical by 877.1% in the 2nd quarter. Renaissance Technologies LLC now owns 102,700 shares of the company’s stock worth $181,000 after purchasing an additional 92,189 shares in the last quarter. Finally, Corsair Capital Management L.P. purchased a new stake in Rockwell Medical in the 3rd quarter valued at about $298,000. 23.31% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the company. RODMAN&RENSHAW upgraded Rockwell Medical to a “strong-buy” rating in a research note on Thursday, November 14th. StockNews.com cut Rockwell Medical from a “buy” rating to a “hold” rating in a research report on Friday, December 20th. HC Wainwright reaffirmed a “buy” rating and set a $7.00 target price on shares of Rockwell Medical in a research report on Monday. Finally, Rodman & Renshaw started coverage on shares of Rockwell Medical in a report on Thursday, November 14th. They issued a “buy” rating and a $5.00 price target on the stock.

Rockwell Medical Price Performance

NASDAQ RMTI opened at $2.15 on Wednesday. The firm’s 50-day simple moving average is $2.86 and its two-hundred day simple moving average is $2.71. The company has a market cap of $69.49 million, a PE ratio of -43.00 and a beta of 1.38. Rockwell Medical, Inc. has a 52 week low of $1.16 and a 52 week high of $5.15. The company has a quick ratio of 2.00, a current ratio of 2.41 and a debt-to-equity ratio of 0.33.

Rockwell Medical Company Profile

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.